These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28497260)

  • 1. A Physiologically Based Pharmacokinetic Perspective on the Clinical Utility of Albumin-Based Dose Adjustments in Critically Ill Patients.
    T'jollyn H; Vermeulen A; Van Bocxlaer J; Colin P
    Clin Pharmacokinet; 2018 Jan; 57(1):59-69. PubMed ID: 28497260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
    Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
    Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
    Ikawa K; Morikawa N; Ikeda K; Suyama H
    J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.
    Roberts JA; Udy AA; Jarrett P; Wallis SC; Hope WW; Sharma R; Kirkpatrick CM; Kruger PS; Roberts MS; Lipman J
    J Antimicrob Chemother; 2015 May; 70(5):1495-502. PubMed ID: 25608584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.
    Fukuchi Y; Toshimoto K; Mori T; Kakimoto K; Tobe Y; Sawada T; Asaumi R; Iwata T; Hashimoto Y; Nunoya KI; Imawaka H; Miyauchi S; Sugiyam Y
    J Pharm Sci; 2017 Sep; 106(9):2704-2714. PubMed ID: 28465151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
    Stepensky D
    Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.
    De Cock RF; Smits A; Allegaert K; de Hoon J; Saegeman V; Danhof M; Knibbe CA
    J Antimicrob Chemother; 2014 May; 69(5):1330-8. PubMed ID: 24492261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
    Vanstraelen K; Wauters J; Vercammen I; de Loor H; Maertens J; Lagrou K; Annaert P; Spriet I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6782-9. PubMed ID: 25182655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
    Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C
    Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
    de Maat MM; van Leeuwen HJ; Edelbroek PM
    Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels.
    Kurland S; Furebring M; Löwdin E; Eliasson E; Nielsen EI; Sjölin J
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.